The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Bonus Oct 18, 1999 Nov 05, 1999 Oct 07, 1999 Bonus Ratio: 2 share(s) for every 1 shares held Rights Feb 03, 1995 Mar 02, 1995 May 03, 1995 Rights ratio: 4 share for every 50 held at a price of Rs ...

The plant got the go-ahead from the US FDA in October 2024. With the green signal, “Cipla now expects to launch the product in 1HFY26 vs its guidance of a launch in 2HFY26E," Nomura said in a ...

Cipla Limited is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and ...

Cipla Foundation, along with CanSupport, have expanded free palliative home care services in Pune. With nine dedicated home care teams, the initiative will provide supportive care to more than 900 ...

Cipla share price: Pharmaceutical major Cipla shares were in demand on Friday, April 11, 2025, as the scrip popped up to 5.11 per cent to hit an intraday high of ₹1,488.80, upon securing USFDA ...

For the quarter, net profit soared 49% on-year to ₹1,570 crore, on the back of higher revenue and better operating efficiency.

Cipla Ltd. is a Public Limited Listed company incorporated on 17/08/1935 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is ...

Cipla is currently priced at Rs 1511.40, showing a decline of 0.26% today. The 3-day exponential moving average stands at Rs 1515.16. Cipla is currently valued at Rs 1513.7, experiencing a small drop ...

The American Lung Association in New York is proud to welcome Cipla back as the lead sponsor of the 2025 LUNG FORCE Walk New York City. As this year’s Breathe Free Sponsor, Cipla continues its ...

Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment drug. The company has received the final approval from the US Food and ...